Abstract.
Undifferentiated and NGF-treated PC12 cells were subjected to anoxia for up to 24 h. The adenosine A2A receptor antagonist 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4 triazolo[1,5-c]pyrimidine (SCH 58261) decreased viability of undifferentiated, but not NGF-treated PC12 cells after 6 h of anoxia. Anoxia also transiently enhanced cAMP responses induced via activation of adenosine A2A receptors in undifferentiated PC12 cells (20-fold decrease in the EC50 value for the agonist 2-[p-(2-carbonylethyl) phenylethylamino]-5'-N-ethylcarboxamidoadenosine, CGS 21680). In NGF-treated PC12 cells, by contrast, anoxia decreased both the maximal response to and the potency of CGS 21680. In undifferentiated PC12 cells subjected to anoxia a very modest increase of A2A receptor mRNA was detected in cells by Northern blotting, but no changes in the amount of the receptor protein could be seen by Western blotting. However, surface biotinylation of the cells followed by avidin pull-down showed that the A2A receptor at the cell membrane was increased after anoxia. This was supported by immunolabelling of the A2A receptors: much of the receptor protein was present in the cytoplasm of normoxic cells, but in cells subjected to anoxia the A2A receptor immunolabelling at the cell membrane was more pronounced, indicating redistribution of the receptors from intracellular pools to the cell membrane during anoxia.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Arslan, G., Kull, B. & Fredholm, B.B. Anoxia redistributes adenosine A2A receptors in PC12 cells and increases receptor-mediated formation of cAMP. Naunyn-Schmied Arch Pharmacol 365, 150–157 (2002). https://doi.org/10.1007/s002100100456
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002100100456